Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 7,751–7,775 of 7,816 matching trials · page 311 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia NCT00209456 DatSCAN Runs in: Germany · 1 site |
PHASE3 other |
COMPLETED | 326 | GE Healthcare INDUSTRY |
2007-05-16 |
|
Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease NCT00467766 Psychosocial information, counseling, and support; Donepezil (Aricept) Runs in: Australia; United Kingdom; United States · 3 sites |
NA symptomatic-cholinergic |
COMPLETED | 300 | Pfizer INDUSTRY |
2007-05-07 |
|
Atrial Fibrillation and the Risk for Neurological Complications NCT00357227 Runs in: Germany · 1 site |
NA other |
UNKNOWN | 1,000 | University Hospital Muenster OTHER |
2007-04-19 |
|
GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease NCT00414622 DMXB-A Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 60 | CoMentis INDUSTRY |
2007-04-19 |
|
Implementation Study of Dementia Guidelines in Primary Care NCT00459784 Dementia Training Program Runs in: Netherlands · 1 site |
NA other |
UNKNOWN | 200 | Radboud University Medical Center OTHER |
2007-04-13 |
|
Rapid Tranquillization Trial: TREC-India II NCT00455234 Intramuscular Olanzepine 10 mg; Intramuscular Haloperidol 5-10 mg +... Runs in: India · 1 site |
PHASE3 other |
COMPLETED | 300 | Christian Medical College, Vellore, India OTHER |
2007-04-03 |
|
The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD) NCT00145691 Oxcarbazepine Runs in: Norway · 1 site |
PHASE3 other |
COMPLETED | 100 | Sykehuset Innlandet HF OTHER |
2007-03-21 |
|
Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia NCT00450047 Speed-feedback therapy system with a bicycle ergometer; Ergometer a... |
PHASE4 other |
COMPLETED | 120 | Hiroshima University OTHER |
2007-03-21 |
|
Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects NCT00366483 Lecozotan SR Runs in: France · 1 site |
PHASE1 other |
COMPLETED | 40 | Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY |
2007-03-16 |
|
Evaluating the Effects of Music Interventions on Hospitalised People With Dementia NCT00448318 Music Therapy Runs in: Australia · 1 site |
PHASE2|PHASE3 other |
UNKNOWN | 180 | National Ageing Research Institute, Australia OTHER |
2007-03-16 |
|
Community-Based Violence Prevention for High-Risk Youth NCT00444197 Mentoring and violence prevention curriculum with parental monitoring Runs in: United States · 2 sites |
PHASE2 other |
COMPLETED | 198 | Johns Hopkins University OTHER |
2007-03-07 |
|
Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease NCT00088673 3APS Runs in: Canada; United States · 67 sites |
PHASE3 other |
UNKNOWN | 950 | Bellus Health Inc. - a GSK company INDUSTRY |
2007-02-28 |
|
Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD NCT00152750 APO-clonidine Runs in: Canada · 1 site |
PHASE4 other |
UNKNOWN | 32 | University Health Network, Toronto OTHER |
2007-02-28 |
|
Screening for Mental Health Concerns for at-Risk Community Living Chinese Seniors NCT00433238 Participants will be screened for depression and cognitive impairme... Runs in: Canada · 1 site |
PHASE1 other |
UNKNOWN | 100 | Mount Sinai Hospital, Canada OTHER |
2007-02-09 |
|
Effect of Indomethacin on the Progression of Alzheimer's Disease NCT00432081 indomethacin Runs in: Netherlands · 2 sites |
PHASE3 other |
COMPLETED | 160 | Radboud University Medical Center OTHER |
2007-02-06 |
|
The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients NCT00402311 DOC-PG: integrated multidisciplinary assessment; Usual care: assess... Runs in: Netherlands · 1 site |
NA other |
COMPLETED | 216 | Maastricht University Medical Center OTHER |
2007-01-22 |
|
Trial of Safety Nets In Hospitalized Patients NCT00409370 SOMA safe enclosure Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 60 | Griffin Hospital OTHER |
2006-12-08 |
|
PACT: Providers and Alzheimer's Caregivers Together NCT00182897 Skills Building for Caregiver Health and Care-recipient Runs in: United States · 1 site |
NA other |
COMPLETED | 120 | National Institute on Aging (NIA) NIH |
2006-11-14 |
|
Lipitor as a Treatment for Alzheimer's Disease NCT00024531 Atorvastatin calcium Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 98 | Institute for the Study of Aging (ISOA) OTHER |
2006-11-09 |
|
Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's Disease NCT00391833 Panax Ginseng |
PHASE1|PHASE2 other |
COMPLETED | — | Seoul National University Hospital OTHER |
2006-10-24 |
|
Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates NCT00203775 risperidone Runs in: United States · 1 site |
NA other |
TERMINATED | — | University of Connecticut OTHER |
2006-10-13 |
|
Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease NCT00100282 PPI-1019 (APAN) Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 125 | PRAECIS Pharmaceuticals Inc. INDUSTRY |
2006-09-19 |
|
Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease NCT00100334 PPI-1019 (APAN) Runs in: United States · 1 site |
PHASE1|PHASE2 other |
COMPLETED | 24 | PRAECIS Pharmaceuticals Inc. INDUSTRY |
2006-09-19 |
|
COGNIShunt® System for Alzheimer's Disease NCT00056628 The COGNIShunt® System |
PHASE3 other |
COMPLETED | 250 | Eunoe INDUSTRY |
2006-09-12 |
|
Positron Emission Tomography of Amyloid in Alzheimer's Disease NCT00205621 Positron Emission Tomography Runs in: Netherlands · 1 site |
PHASE1 other |
SUSPENDED | 50 | Amsterdam UMC, location VUmc OTHER |
2006-09-08 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial